NABARD Grade A Result 2025–26 is out for Phase 1. Candidates can check phase 2 Exam date, download pdf, steps to check, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Prior to this trial, CS014 had positive outcomes in an ...

Nucleus had 154 phase-1 beds, or 39.4 per cent market share, in Australia according to a 2025 report published by the ACCC.

Phase 1 trial shows MBX 1416 is safe and well-tolerated, advancing to Phase 2 for PBH in late 2025. MBX Biosciences announced positive Phase 1 clinical trial results for its investigational drug MBX ...

In a significant breakthrough for the development of supercritical carbon dioxide (sCO 2) power cycles, the 10-MWe Supercritical Transformational Electric Power (STEP) Demo pilot plant in San Antonio, ...

Capsida Biotherapeutics has paused a gene therapy trial after the first patient died. The biotech, which began the phase 1/2 study in July, took the action to give it time to determine the “root cause ...

Vigil Neuroscience reported positive Phase 1 trial results for VG-3927 and plans a Phase 2 trial in Q3 2025. Vigil Neuroscience, Inc. announced promising outcomes from a Phase 1 clinical trial of ...

Casdatifan, an HIF-2α inhibitor, showed a 33% objective response rate in ccRCC patients at a 100 mg daily dose. The drug targets hypoxia-inducible factor-2 alpha to disrupt tumor-promoting mechanisms ...

-- 30.2-month median progression-free survival with a median follow-up of 38.1 months in the Phase 1 study of anito-cel; median overall survival not reached -- -- Preliminary results from 58 patients ...

Interim data from Phase 1 with single and multiple ascending doses show no safety signals and a generally favorable tolerability profile of AGMB-447 in healthy participants -- ...